Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2026 Sep 5.
Published in final edited form as: Lancet Infect Dis. 2026 Jun 9;26(7):e279–e280. doi: 10.1016/S1473-3099(26)00299-9

Estimation of the size of the Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo

Ruth McCabe 1, Lennox Ebbarnezh 2, Solome Okware 3, Richard Fotsing 4, Etien Koua 5, Paul Mbaka 6, Adelard Lofungola 7, Dav M Ebengo 8,9, Placide K Mbala 8,9,10, Tania T Bishola 8,9,11, Christian M Ibolobolo 9, Herman M Matondo 8,9, Jean-Clement M Sibo 8,9, Sabine L van Elsland 1, Martina McMenamin 2, Neil M Ferguson 1, Olivier le Polain de Waroux 2,*, Anne Cori 1,*,#
PMCID: PMC7619448  EMSID: EMS218038  PMID: 42263719

The ongoing outbreak of Bundibugyo virus disease (BVD), a form of Ebola virus disease caused by the Bundibugyo virus, in the Democratic Republic of the Congo (DRC) is evolving rapidly. As of 27 May 2026, a total of 1,031 suspected or confirmed cases of BVD had been reported from fourteen health zones across three provinces (Ituri, Nord Kivu, Sud Kivu) DRC including 240 suspected or confirmed deaths.1 Testing has rapidly expanded for routine and retrospective assessment of suspected cases (381 confirmed cases as of 3 June 2026). Deaths are harder to retrospectively assess, with investigations ongoing (64 confirmed deaths as of 3 June 2026). Suspected cases and deaths are no longer reported in recent situation reports.2 An additional sixteen cases were confirmed in Uganda, as of 4 June 2026,3 with three of those among individuals travelling from Ituri Province, DRC (Uganda Ministry of Health 23 May 2026; World Health Organization 29 May 2026).4,5 Together, these observations suggest that the epidemic is larger than currently ascertained; however, its true magnitude remains uncertain. Estimating the outbreak size is important to assess the scale of the public health threat and to appropriately calibrate surveillance and response efforts.

To produce early estimates of the current size of the epidemic in the DRC as of 27 May 2026, we conducted scenario-based analyses using two simple, independent approaches, leveraging the limited information currently available and making plausible assumptions about the surveillance, severity, and growth of the outbreak (full methodological detail in Appendix).

The first method uses an analytical framework linking reported suspected and confirmed deaths, of which we assume a proportion is due to Ebola, with estimates of the case fatality ratio (CFR; proportion of cases who die as a result of a Bundibugyo infection; 33% 95% CI 26-40%) and the time from symptom onset to death (gamma distributed, mean 11.37 days, standard deviation 5.41 days) derived from previous Bundibugyo virus outbreaks.6,7 We further assume exponential epidemic growth following a single zoonotic spillover event.8 Assuming 30% of suspected and confirmed deaths are due to Ebola virus disease, a case fatality ratio of 33% and a doubling time of 10 days yields a mean estimated outbreak size of 451 cases (95% CI 396–511) as of 27 May 2026 (Table 1). Estimated outbreak size increases with assumptions of a higher proportion of deaths due to Ebola, a lower case fatality ratio, and fast epidemic growth.

Table 1.

Estimated outbreak sizes derived using method 1 (backcalculation from 240 reported suspected and confirmed deaths), under 3 assumptions for the epidemic growth rate (a main scenario with a 10-day doubling time, and two sensitivity analyses with 7- and 14- day doubling times) and 3 estimates of the CFR. 95% confidence intervals derived assuming Poisson variation shown. The results assuming 100% of suspected and confirmed deaths are due to Ebola virus disease are presented in the Appendix.

Scenario Doubling time (days) Corresponding growth rate (per day) Number of cases: Mean (95%CI)
CFR = 26% CFR = 33% CFR = 40%
Main scenario: Moderate growth, intermediate emergence 10 0.07 573
(502 - 648)
451
(396 - 511)
372
(327 - 421)
Sensitivity analysis 1:
Fast growth, recent emergence
7 0.1 756
(664 - 855)
596
(523 - 674)
491
(432 - 556)
Sensitivity analysis 2:
Slow growth, older emergence
14 0.05 471
(413 - 533)
371
(326 - 420)
306
(269 - 346)

The second method extends the method described by Imai et al.9. We combine information on the three confirmed imported BVD cases reported in Uganda (as of 27 May 2026); estimates of daily international travel volumes from Ituri and Nord Kivu provinces to Uganda; assumptions about the epidemic doubling time, and we presumed that all cases in symptomatic travellers will be detected at the time of recovery or death.6,7 Assuming Ituri province as the source population, and a doubling time of 10 days, this approach yields an estimated outbreak size of 945 (95% CI 196-2,274) cases. Expanding the source population to further include Nord Kivu increases these estimates (Table 2). However, these findings should be interpreted with caution, as at least two of the three imported cases reportedly travelled to Uganda specifically to seek medical care.10 Assuming fewer travellers reduces the epidemic size accordingly (Appendix).

Table 2.

Estimated outbreak size derived using method 2 (geographic spread), under two assumptions regarding the source populations (main assumption: source population = Ituri, sensitivity analysis: source population = Ituri + Nord Kivu), assuming all cases in symptomatic travellers will be detected by the time of recovery or death, given three observed imported cases into Uganda. Confidence intervals (CIs) calculated as exact negative binomial CIs. The results assuming only one imported case are shown in the Appendix.

Scenario Doubling time Corresponding growth rate Number of cases: Mean (95% CI)
Ituri province
Population: 4,392,200
Ituri and Nord Kivu provinces
Population: 12,593,600
Main scenario: Moderate growth, intermediate emergence 10 0.07 945 (196 - 2,274) 1,164 (241 - 2,800)
Sensitivity analysis 1: Fast growth, recent emergence 7 0.1 1,100 (228 - 2,647) 1,354 (281 - 3,260)
Sensitivity analysis 2: Slow growth, older emergence 14 0.05 847 (176 - 2,037) 1,042 (216 - 2,508)

The two simple methods yield broadly consistent results, suggesting that as of 27 May 2026, approximately 280 to 2,520 cases of BVD may have occurred in the DRC (estimate range: 306 – 2,521 under death back-calculation model; 282 – 1,345 under geographical spread model). However, there is considerable uncertainty around these estimates. Nonetheless, the broad convergence of estimates from two independent methods supports the conclusion of considerable under-detection and the potential for wider transmission.

As with all modelling approaches, these estimates rely on several key assumptions: that transmission is largely concentrated in Ituri and Nord Kivu provinces; the scale and patterns of population movement from these areas to Uganda are accurately captured within the point of entry data used; the percentage of deaths attributable to Ebola is between 30% and 100%; the CFR and time between onset and death in this outbreak are consistent with those derived from past Bundibugyo virus outbreaks; and the current epidemic growth rate is between 7 - 14 days, loosely based on early genomic analyses.11 Each of these assumptions is subject to substantial uncertainty which may influence the resulting estimates. A full list of caveats is provided in the appendix. We underline that this is an early analysis, primarily conducted to inform operational planning, and that estimates will change as more data and information about the outbreak become available.

To guide response efforts, it is important that the size, growth rate and geographic extent of the epidemic are better characterised as soon as possible; both epidemiological (e.g. case time series) and genomic data (informing estimates of the time of the most recent common ancestor, e.g. Mbala et al. 2026) will be critical to achieve this goal.

These findings point to potentially substantial undetected transmission of BVD in eastern DRC. Importantly, these estimates highlight the large human burden of the outbreak. Rapid, targeted public health interventions, urgent medical support for affected and at-risk populations and strong international coordination are essential.

Supplementary Material

Appendix

Funding statement

RM, SvE, NMF and AC acknowledge funding from the Medical Research Council (MRC) Centre for Global Infectious Disease Analysis (MR/X020258/1) funded by the UK MRC and carried out in the frame of the Global Health EDCTP3 Joint Undertaking supported by the EU. DME wishes to thank the European Union – Horizon Europe / EDCTP3 Joint Undertaking for supporting this work through the EBOLA PREP TBOX project (Grant Agreement No. 101145709). NMF and AC acknowledge the National Institute for Health Research (NIHR) Health Protection Research Unit in Health Analytics & Modelling (NIHR207404), a partnership between UK Health Security Agency (UKHSA), London School of Hygiene & Tropical Medicine, and Imperial College of Science, Technology, & Medicine, and also thank Community Jameel for philanthropic funding of the Jameel Institute.

Footnotes

Declaration of interests

The authors declare no competing interests.

Author contributions

RM, LK, MM, NMF, OLP and AC conceptualised the study. LK, SO, RF, EK, PM, AL, DME, PKM, TTB, CMI, HMM, MM, J-CMS and OLP curated the data. RM, NMF and AC conducted the formal analysis in the paper. RM, SvE, NMF and AC wrote the first draft. All authors contributed to redrafting.

Code availability

All code to reproduce these analyses can be found at: https://github.com/mrc-ide/evd-2026-outbreak-size.

References

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix

Data Availability Statement

All code to reproduce these analyses can be found at: https://github.com/mrc-ide/evd-2026-outbreak-size.

RESOURCES